Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IL-22 anticorps (Biotin)

IL22 Reactivité: Humain ELISA, ELISpot Hôte: Rat Monoclonal MT7B27 Biotin
N° du produit ABIN6963887
  • Antigène Voir toutes IL-22 (IL22) Anticorps
    IL-22 (IL22) (Interleukin 22 (IL22))
    Reactivité
    • 75
    • 47
    • 26
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 66
    • 12
    • 12
    • 9
    Rat
    Clonalité
    • 77
    • 21
    • 1
    Monoclonal
    Conjugué
    • 51
    • 16
    • 7
    • 4
    • 4
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp IL-22 est conjugé à/à la Biotin
    Application
    • 74
    • 46
    • 32
    • 14
    • 13
    • 13
    • 8
    • 6
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    ELISA, ELISpot
    Specificité
    Native and recombinant IL-22
    Purification
    Biotinylated through reaction with a N-hydroxysuccinimide ester of biotin.,Purified from in vitro cultures by protein G affinity chromatography.
    Stérilité
    0.2 μm filtered
    Immunogène
    Recombinant human IL-22
    Clone
    MT7B27
    Isotype
    IgG2a
    Top Product
    Discover our top product IL22 Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.5 mg/mL
    Buffer
    supplied at 0.5 mg/mL in PBS with 0.02 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/ thawing.
    Date de péremption
    18 months
  • Chen, Gomes, Hardman, Vieira Braga, Gutowska-Owsiak, Salimi, Gray, Duncan, Reynolds, Johnson, Salio, Cerundolo, Barlow, McKenzie, Teichmann, Haniffa, Ogg: "Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation." dans: The Journal of experimental medicine, Vol. 217, Issue 3, (2020) (PubMed).

    Monroy-Arreola, Durán-Figueroa, Méndez-Flores, Domínguez-Cherit, Watkinson, Badillo-Corona, Whitaker, Naisbitt, Castrejón-Flores: "Up-Regulation of T-Cell Activation MicroRNAs in Drug-Specific CD4+ T-Cells from Hypersensitive Patients." dans: Chemical research in toxicology, Vol. 31, Issue 6, pp. 454-461, (2019) (PubMed).

    Ashrafi, Shapouri, Mahdavi: "Immunological consequences of immunization with tumor lysate vaccine and propranolol as an adjuvant: A study on cytokine profiles in breast tumor microenvironment." dans: Immunology letters, Vol. 181, pp. 63-70, (2017) (PubMed).

    Gibson, Kim, Faulkner, Evely, Pirmohamed, Park, Naisbitt: "In Vitro Priming of Naı̈ve T-cells with p-Phenylenediamine and Bandrowski's Base." dans: Chemical research in toxicology, Vol. 28, Issue 10, pp. 2069-77, (2016) (PubMed).

  • Antigène
    IL-22 (IL22) (Interleukin 22 (IL22))
    Autre désignation
    IL22 (IL22 Produits)
    Synonymes
    anticorps IL-21, anticorps IL-22, anticorps IL-D110, anticorps IL-TIF, anticorps ILTIF, anticorps TIFIL-23, anticorps TIFa, anticorps zcyto18, anticorps IL-22a, anticorps ILTIFa, anticorps Iltif, anticorps RGD1561292, anticorps interleukin-22, anticorps interleukin 22, anticorps IL22, anticorps il22, anticorps Il22
    ID gène
    50616
Vous êtes ici:
Support technique